First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Reaches New 1-Year High – What’s Next?

Posted by Dante Gardener on Jul 6th, 2026

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as $255.39 and last traded at $254.5860, with a volume of 39971 shares traded. The stock had previously closed at $255.37.

First Trust NYSE Arca Biotechnology Index Fund Trading Up 1.4%

The company has a market cap of $2.87 billion, a price-to-earnings ratio of 21.72 and a beta of 0.65. The stock’s 50-day moving average is $221.22 and its 200-day moving average is $212.13.

Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Institutional investors have recently made changes to their positions in the stock. Cornell Pochily Investment Advisors Inc. acquired a new position in First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter worth approximately $220,000. HF Advisory Group LLC grew its stake in First Trust NYSE Arca Biotechnology Index Fund by 4.5% in the fourth quarter. HF Advisory Group LLC now owns 1,437 shares of the company’s stock valued at $297,000 after acquiring an additional 62 shares during the period. Nilsine Partners LLC acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at approximately $1,082,000. Quad Cities Investment Group LLC increased its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 0.9% during the fourth quarter. Quad Cities Investment Group LLC now owns 8,445 shares of the company’s stock valued at $1,744,000 after acquiring an additional 72 shares in the last quarter. Finally, Stablepoint Partners LLC increased its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 2.2% during the fourth quarter. Stablepoint Partners LLC now owns 4,980 shares of the company’s stock valued at $1,028,000 after acquiring an additional 108 shares in the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

(Get Free Report)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.